Protalix BioTherapeutics, Inc. Income Taxes Paid
Protalix BioTherapeutics, Inc. (PLX) reported Income Taxes Paid of $2.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. income taxes paid, net for the quarter ending 2026-06-30 was $0.00.
- Protalix BioTherapeutics, Inc. income taxes paid, net for the quarter ending 2026-03-31 was $2.50M.
- Protalix BioTherapeutics, Inc. income taxes paid, net for the quarter ending 2025-12-31 was $1.00K.
- Protalix BioTherapeutics, Inc. income taxes paid, net for fiscal 2025 was $1.18M, a 207.27% increase from fiscal 2024.
- Protalix BioTherapeutics, Inc. income taxes paid, net for fiscal 2024 was $385.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.50M 10-Q · filed 2026-08-12 | $2.50M derived: sum of 3 quarters · filed 2026-08-12 | |
| 2026-03-31 | $2.50M 10-Q · filed 2026-05-13 | $2.50M derived: sum of 2 quarters · filed 2026-05-13 | ||
| 2025-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $1.18M 10-K · filed 2026-03-18 | ||
| 2025-09-30 | $1.18M 10-Q · filed 2025-11-13 | |||
| 2024-12-31 | $385.00K 10-K · filed 2026-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |